Belpointe Asset Management’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-31,667
Closed -$38K 3684
2023
Q1
$38K Hold
31,667
﹤0.01% 1876
2022
Q4
$45K Sell
31,667
-10,533
-25% -$22.6K ﹤0.01% 1677
2022
Q3
$103K Buy
+42,200
New +$141K 0.01% 1145
2022
Q2
Sell
-51,200
Closed -$345K 1295
2022
Q1
$345K Buy
51,200
+19,000
+59% +$162K 0.02% 668
2021
Q4
$291K Buy
+32,200
New +$299K 0.02% 728

Other funds holding DBD

Belpointe Asset Management's DBD Position: Q2 2023 in Review

Belpointe Asset Management sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 31,667 shares — an estimated $38K sold.

Belpointe Asset Management first reported a position in DBD in Q4 2021 and held it in 5 quarters. The position peaked at $345K in Q1 2022. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Belpointe Asset Management reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 31,667 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $38K.
  • Belpointe Asset Management first reported a position in Diebold Nixdorf Incorporated in Q4 2021 and held it in 5 quarters.
  • Belpointe Asset Management's Diebold Nixdorf Incorporated position peaked at $345K in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.